BRCA1 and cancer: KSQ4279 demonstrated hyperactive in cancer cells with HRD or BRCA deficiencies in vitro and in vivo.331 Of note, KSQ4279 led to cell cycle arrest, accumulated DNA damage and replication fork degradation in BRCA1 deficient cells, which is consistent with USP1 biological functions.